FDA Drugs recall ·

Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle… recall

Recall number
D-0001-2025
Date
(initiated September 24, 2024)
Company / brand
Nivagen Pharmaceuticals Inc
3100 Fite Cir, Sacramento, CA, United States
Category
Drugs › Class II
Classification
Class II
Status
Terminated
Units affected
2328 bottles
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA, Manufactured by: Umedica Laboratories Pvt Ltd., Vapi Gujarat 396195, India, NDC: 75834-257-01.

Why was it recalled?

Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot #: U24T0408A, Exp: 03/31/2026

Distribution

Nationwide within the U.S

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0001-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.